These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29390577)

  • 1. 24-month HIV-free survival among infants born to HIV-positive women enrolled in Option B+ program in Kigali, Rwanda: The Kabeho Study.
    Gill MM; Hoffman HJ; Ndatimana D; Mugwaneza P; Guay L; Ndayisaba GF; Bobrow EA; Asiimwe A; Mofenson LM
    Medicine (Baltimore); 2017 Dec; 96(51):e9445. PubMed ID: 29390577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
    PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-Month HIV-free survival among HIV-exposed Infants in Lesotho: the PEAWIL cohort study.
    Tukei VJ; Machekano R; Gill MM; Tiam A; Mokone M; Isavwa A; Nyabela M; Mots'oane T; Nchephe S; Letsie M; Kassaye SG; Guay L
    J Int AIDS Soc; 2020 Dec; 23(12):e25648. PubMed ID: 33314744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda.
    Mugwaneza P; Lyambabaje A; Umubyeyi A; Humuza J; Tsague L; Mwanyumba F; Mutabazi V; Nsanzimana S; Ribakare M; Irakoze A; Mutaganzwa E; Lombard C; Jackson D
    BMC Public Health; 2018 Nov; 18(1):1248. PubMed ID: 30419870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 6-week PMTCT outcomes for HIV-exposed and HIV-unexposed infants in the era of lifelong ART: Results from an observational prospective cohort study.
    Tiam A; Kassaye SG; Machekano R; Tukei V; Gill MM; Mokone M; Letsie M; Tsietso M; Seipati I; Barasa J; Isavwa A; Tylleskär T; Guay L
    PLoS One; 2019; 14(12):e0226339. PubMed ID: 31877153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.
    Chi BH; Mutale W; Winston J; Phiri W; Price JT; Mwiche A; Ayles H; Stringer JSA
    Pediatr Infect Dis J; 2018 Nov; 37(11):1137-1141. PubMed ID: 29601456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal interrelationship between HIV viral suppression, maternal weight change, breastfeeding, and length in HIV-exposed and uninfected infants participating in the Kabeho study in Kigali, Rwanda.
    Lane C; Adair L; Bobrow E; Ndayisaba GF; Asiimwe A; Mugwaneza P
    Ann Epidemiol; 2021 Jan; 53():1-6.e1. PubMed ID: 32805400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
    Larsen A; Magasana V; Dinh TH; Ngandu N; Lombard C; Cheyip M; Ayalew K; Chirinda W; Kindra G; Jackson D; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):789. PubMed ID: 31526366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical HIV transmission within 18 months post partum among women on lifelong antiretroviral therapy for HIV in Dar es Salaam, Tanzania: a prospective cohort study.
    Lyatuu GW; Urrio R; Naburi H; Lyaruu P; Simba B; Siril H; Philipo E; Machumi L; Kibao A; Kajoka D; Nyamhagatta M; Sando D; Biberfeld G; Orsini N; Kilewo C; Ekström AM
    Lancet HIV; 2023 Jan; 10(1):e33-e41. PubMed ID: 36495896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis.
    Abimpaye M; Kirk CM; Iyer HS; Gupta N; Remera E; Mugwaneza P; Law MR
    PLoS One; 2018; 13(2):e0192910. PubMed ID: 29451925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
    Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
    Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.